At a time of rapid growth in the consumer genetics space, PerkinElmer and NorthShore are developing digital apps to ease access to genetic disease risk information through Helix.
PerkinElmer is working on an app that reports pathogenic or likely pathogenic ACMG-59 genetic variants, and NorthShore's app will report a prostate cancer risk score.
Researchers will study the genetic underpinnings of cancer, heart disease, and respiratory illness by delving into the exome sequencing data from 40,000 Northern Nevadans.
Helix expects its online store will grow this year to include more than 50 genomics apps, including new health products from partners like Geisinger and Mayo.
Growing interest in precision medicine is spurring genetic testing services claiming to personalize diets, but Janssens' research indicates the evidence is still lacking.
American customers' interest in their genetic ancestry continues to be the primary driver of the consumer genomics market and shows no signs of diminishing.
Following a successful pilot with 23andMe, the Healthy Nevada Project partners with Helix to increase the depth of genomics data while giving participants access to DNA results.
The Healthy Nevada Project will enroll an additional 40,000 participants to be exome sequenced through Helix and receive a free app from its online genomics marketplace.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.
